Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2010
10/19/2010US7816519 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
10/19/2010US7816406 such as 2-Methylsulfanyl-5-oxo-5H-7-thia-1,3,11b-triaza-benzo[c]fluorene-6-carboxylic acid ethyl ester; antiproliferative agents; apoptosis inducers
10/19/2010US7816369 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/19/2010US7816368 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one, used as anticarcinogenic or antitumor agents
10/19/2010US7816365 Amine derivatives
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010CA2525245C Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/19/2010CA2436589C Heterocyclic compounds and cognitive enhancers comprising the same as effective components
10/19/2010CA2417629C Derivatives of variolin b
10/19/2010CA2409743C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/19/2010CA2399840C Use of roflumilast or pumafentrine in combination with methotrexate for the treatment of arthritic diseases
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/15/2010CA2701088A1 Fluorine-substituted perylenes for colour filters in lcds
10/14/2010WO2010118078A1 Macrocyclic serine protease inhibitors
10/14/2010WO2010117936A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
10/14/2010WO2010117935A1 Compounds and methods for antiviral treatment
10/14/2010WO2010117926A1 Substituted triazolopyridines and analogs thereof
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2010116302A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010WO2010116122A2 Herbicidal compounds
10/14/2010WO2010115901A1 Pyrrolopyridine therapeutic compounds
10/14/2010WO2010115780A1 Spiroheterocyclic pyrrolidine dione derivatives used as pesticides
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115342A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO [4, 3-b] INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/14/2010WO2010057104A3 Pyridoindole modulators of nmda receptor and acetylcholinesterase
10/14/2010WO2010041218A3 Oxazolidinyl antibiotics
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010US20100261909 Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
10/14/2010US20100261903 Phosphonate fluorescent dyes and conjugates
10/14/2010US20100261901 Selective bromination of perylene diimides and derivatives thereof under mild conditions
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261751 Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic activities
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/14/2010US20100261730 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260710 Macrocyclic serine protease inhibitors
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2758019A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010CA2757665A1 Herbicidal compounds
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/13/2010EP2239263A1 Cyclic compound, its metal complex, and modified metal complex
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2238138A1 Tricyclic nitrogen compounds and their use as antibacterial agents
10/13/2010EP2238137A1 Compounds and compositions as kinase inhibitors
10/13/2010EP2238136A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist
10/13/2010EP2238135A1 Naphthyridin-2(1h) -one compounds useful as antibacterials
10/13/2010EP2102201B1 Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators
10/13/2010EP2094696B1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists
10/13/2010EP2041133B1 Derivatives of imidazo [1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN1982311B Synthesis of 2-hydrophobic-5-methoxy-diazole [4,5-b]-dipyridine
10/13/2010CN101861316A Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
10/13/2010CN101857595A Quinnazolidone derivative, preparation method thereof and purpose of serving as anticarcinogen
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101084217B Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
10/12/2010US7812166 Kinase inhibitors
10/12/2010US7812165 6-substituted pyridoindolone derivatives, production and therapeutic use thereof
10/12/2010US7812158 Coupling agents for peptide synthesis
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812026 Imidazole derivatives having a positive allosteric GABAB receptor modulator effect and methods of use
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812022 protein tyrosine kinase inhibitors such as 2,6-Difluoro-N-[3-(3-{2-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino]-4-pyrimidinyl}pyrazolo[1,5-a]pyridin-2-yl)phenyl]benzamide, used as anticarcinogenic or antitumor agents
10/12/2010US7812018 inhibitors of I kappa B kinase ( IKK-2) 2-amino-9-methyl-9H-pyrido[2,3-b]indole-3-carboxamide, useful for treating inflammatory diseases and cancer
10/12/2010US7812016 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
10/12/2010US7811681 Electron transport compound and organic light emitting device comprising the same
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010114928A2 Compositions and uses thereof
10/07/2010WO2010114905A1 Peri-fused pyrazolo-pyrimidine compounds
10/07/2010WO2010114904A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
10/07/2010WO2010114902A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
10/07/2010WO2010114898A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
10/07/2010WO2010114267A2 Organic electronic device, compounds for same, and terminal
10/07/2010WO2010113942A1 Indolizine derivative and use thereof for medical purposes
10/07/2010WO2010112826A2 Herbicidal compounds
10/07/2010WO2010112124A1 Autotaxin inhibitors
10/07/2010WO2010111934A1 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof
10/07/2010WO2010111822A1 Oligocondensed perylene bisimides
10/07/2010WO2010091067A3 Derivatives of [1, 3] oxazin- 2-one useful for the treatment of metabolic diseases such as lipid disorders
10/07/2010US20100256698 Isoquinolinone Potassium Channel Inhibitors
10/07/2010US20100256379 Anti-viral agent containing heterocyclic aromatic compound as active ingredient
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 646